Skip to main content
. 2014 Nov 24;26(2):82–93. doi: 10.1089/hum.2014.100

FIG. 2.

FIG. 2.

Percentage of GFP-positive cells in intracranial tumor increases with increasing titers of intravenously administered Toca GFP. (a) Representative fluorescence images of mouse brain; FACS data of tumor and spleen on day 14 for all seven groups. (b) Percentage of GFP-positive cells within the tumor from day 11 to day 14.